↓ Skip to main content

The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study

Overview of attention for article published in BMC Urology, June 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study
Published in
BMC Urology, June 2018
DOI 10.1186/s12894-018-0377-9
Pubmed ID
Authors

A. Zachariou, C. Mamoulakis, M. Filiponi, F. Dimitriadis, J. Giannakis, S. Skouros, P. Tsounapi, A. Takenaka, N. Sofikitis

Abstract

Αim of the study was to determine the effect of mirabegron, used for overactive bladder (OAB) treatment, on female sexual function. Eighty five sexually active women suffering from overactive bladder were prospectively enrolled in this study. Females were divided into two groups. In Group A (control), 48 patients received no treatment and in Group B, 37 patients received mirabegron 50 mg/daily for 3 months. Patients were evaluated with FSFI-Gr at the beginning of the study and again after a period of 3 months. In Group B, there was a significant increase post-treatment compared to baseline (p < 0.001) in total FSFI (20.3 (3.8) to 26.6 (4.2)) and all domains (desire: 3.0 (1.2) to 4.8 (1.2)), arousal: 3.0 (0.8) to 4.8 (0.9), lubrication: 3.9 (1.1) to 4.8 (1.2), orgasm: 3.6 (0.8) to 4.8 (1.0), satisfaction: 3.2 (0.4) to 4.0 (0.8) and pain: 3.2 (0.8) to 4.4 (1.2)). In Group A, there were no statistically significant changes in pre- and post-observation values. This study is one of the few demonstrating that management of OAB with mirabegron improves female sexual function. TRN ISRCTN17199301 , 20/10/2017, retrospectively registered.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 21%
Researcher 5 13%
Student > Ph. D. Student 2 5%
Student > Postgraduate 2 5%
Student > Doctoral Student 1 3%
Other 4 11%
Unknown 16 42%
Readers by discipline Count As %
Medicine and Dentistry 10 26%
Nursing and Health Professions 5 13%
Social Sciences 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Psychology 1 3%
Other 3 8%
Unknown 16 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2018.
All research outputs
#4,703,375
of 23,577,761 outputs
Outputs from BMC Urology
#144
of 768 outputs
Outputs of similar age
#88,756
of 330,068 outputs
Outputs of similar age from BMC Urology
#3
of 13 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 768 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,068 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.